Redian新闻
>
求GlobalFoundaries内推
avatar
求GlobalFoundaries内推# EE - 电子工程
l*s
1
在中小板ETF创新高以后,应该把钱rotate到50ETF
avatar
X*r
2
多多关照
avatar
c*n
3
八月回国签过了
圣诞节回去结婚,想跟老婆携签
请问我这样的情况对F2携签可能有什么不好的影响吗?
谢谢
avatar
n*t
4
I sent an email in a standardized form provided by our thesis office to
c*******[email protected] in order to get the copyright permission to include my
published articles in my dissertation. But after two weeks,I haven't
received any response from ACS copyright office. Anyone can give me
suggestions?
avatar
d*c
5
有哪位前辈在GF,求帮忙内推!
或者您的姓名。站内信,多谢!
“If you are hired and referred someone prior to starting you STILL get the
REFERRAL BONUS!!!”
avatar
N*a
6
我两个月前买的石化 联通,一直闷到这两天才扭亏为盈
不过那是我第一次买股,买的不多

【在 l******s 的大作中提到】
: 在中小板ETF创新高以后,应该把钱rotate到50ETF
avatar
c*s
7
你嘛专业的?

【在 X*****r 的大作中提到】
: 多多关照
avatar
z*b
8
预约2个号,但f1不交签证材料,f2签证的时候一起上就行了
avatar
c*6
9
American Chemical Society has partnered with Copyright Clearance Center's
Rightslink service to offer a variety of options for reusing American
Chemical Society content.
In "web of science", find the paper you want and open it. On right column "
tool", you can find "rights & permissions". Click the button, then follow
the instructions. Usually it will take 4-6 weeks to get the permission.
avatar
X*r
10
EE

【在 c****s 的大作中提到】
: 你嘛专业的?
avatar
f*8
11
去网站上找你的文章,右边有个right&permission的链接,点击进去以后照做就可以即时
得到授权,不需要联系copy right office.
avatar
x*8
12
人又少了一个,唉
avatar
n*t
13
Guys, thanks very much!
If others need the same permission, please check the link below:
http://pubs.acs.org/page/copyright/rightslink.html
You will have information on how to get the permission for your articles.

【在 f***8 的大作中提到】
: 去网站上找你的文章,右边有个right&permission的链接,点击进去以后照做就可以即时
: 得到授权,不需要联系copy right office.

avatar
c*b
14
你什么意思啊?

【在 x******8 的大作中提到】
: 人又少了一个,唉
avatar
g*0
15
Enjoy
avatar
D*o
16
I know a guy majored in EE, who got super good offers after 2-yr postdoc.
Good luck and enjoy.
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。